Pathyaപഥ്യം
← New record

IndiPGx-Read D-r03

Lab reportcohort · demo

10/30/2026, 6:25:44 AM · PharmCAT 3.4.0 · Research record, not medical advice

4
Genes standardised
4
Calls quoted
0
Coverage gaps
1
Identifiers removed
25.6s
Upload to record
  1. Muse Sparkread 4 gene calls15.0s
  2. PharmCATstandardised 4 genes10.6s
  3. Rules0 coverage gaps

CallsMuse Spark each call quoted from the source, then standardised by PharmCAT

Example Pharmacogenomics Centre, Mumbai · 16 Oct 2026 · open original photo

Uploaded lab report photo
GeneAs printedStandardisedPhenotype term
CYP2C19“CYP2C19 Phenotype: Poor metabolizer *2 Detected (heterozygous) *3 Detected (heterozygous) *17 Not detected”*2/*3Poor Metabolizer
CYP2D6“CYP2D6 Phenotype: Intermediate metabolizer *2 Not detected *3 Not detected *4 Detected (heterozygous) *5 Not detected *6 Not detected *10 Detected (heterozygous) *41 Not detected”*4/*10Intermediate Metabolizer · activity 0.25
DPYD“DPYD Phenotype: Intermediate metabolizer c.1236G>A (HapB3) Detected (heterozygous) c.85T>C (*9A) Detected (heterozygous) c.1905+1G>A (*2A) Not detected c.1679T>G (*13) Not detected c.2846A>T Not detected”c.85T>C (*9A)/c.1129-5923C>G, c.1236G>A (HapB3)Intermediate Metabolizer · activity 1.5
UGT1A1“UGT1A1 Phenotype: Intermediate metabolizer *28 Detected (heterozygous) *6 Not detected”*1/*28Intermediate Metabolizer

Method as printed: Method: targeted genotyping by real-time PCR. Only the listed variants are assayed; variants outside this panel cannot be excluded.

Coveragedeterministic rules · which India-relevant variants this panel named

DPYDHapB3named on the report

Most common Indian decreased-function DPYD variant (~3.3%, PMID 40810747)

DPYDc.85T>C (*9A)named on the report

~25% in Indians; toxicity signal in South Indian cohorts (PMC11300675)

DPYD*2Anamed on the report

European tier-1 variant; rare in Indians (PMID 40810747)

DPYD*13named on the report

Tier-1 no-function variant (PMID 39032821)

DPYDc.2846A>Tnamed on the report

Tier-1 variant; near-absent in Indians (PMID 40810747)

UGT1A1*28named on the report

TA-repeat allele, common in South Asians

UGT1A1*6named on the report

East Asian allele; reported at low frequency in India

CYP2C19*2named on the report

Common no-function allele in South Asians

CYP2C19*17named on the report

Increased-function allele

A variant the panel did not name is left out of cohort statistics for that variant, rather than counted as absent. A patient or lab reference printed on the report was removed before storage. Reader notes: Only the listed variants are assayed; variants outside this panel cannot be excluded. Synthetic document generated for software benchmarking. Not a real patient or laboratory.

Exportde-identified · the same record in three formats

Curator review

This is a read-only sample. In the pilot, a curator checks each call against the source document before the record counts in a cohort, and Muse Spark web search finds published Indian frequency data for each variant. Both are written to the audit log.

Sign in with the pilot code
Research tool, not medical advice. Pathya reads and standardises pharmacogenomic results; it makes no dose, drug or test recommendation. Audit log: data/cases/402ae53a6a93/audit.log.